Entity Common Stock, Shares Outstanding of CNBX Pharmaceuticals Inc. from 14 Jan 2012 to 12 Jan 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
CNBX Pharmaceuticals Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 14 Jan 2012 to 12 Jan 2026.
  • CNBX Pharmaceuticals Inc. Entity Common Stock, Shares Outstanding for the quarter ending 12 Jan 2026 was 870,768,095, a 2699% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

CNBX Pharmaceuticals Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 870,768,095 +839,656,743 +2699% 12 Jan 2026 10-Q 14 Jan 2026 2026 Q1
Q4 2025 553,962,206 +522,850,854 +1681% 20 Nov 2025 10-K 01 Dec 2025 2025 FY
Q2 2025 92,511,352 +61,400,000 +197% 14 Jul 2025 10-Q 14 Jul 2025 2025 Q3
Q1 2025 4,196,841 -26,914,511 -87% 14 Apr 2025 10-Q 14 Apr 2025 2025 Q2
Q4 2024 31,111,352 0 0% 12 Jan 2025 10-Q 13 Jan 2025 2025 Q1
Q2 2024 31,111,352 +14,077,620 +83% 14 Jul 2024 10-Q 15 Jul 2024 2025 Q3
Q1 2024 31,111,352 +26,145,155 +526% 12 Apr 2024 10-Q 16 Apr 2024 2024 Q2
Q4 2023 31,111,352 +29,853,425 +2373% 12 Jan 2024 10-Q 12 Jan 2024 2024 Q1
Q2 2023 17,033,732 +15,775,805 +1254% 14 Jul 2023 10-Q 14 Jul 2023 2023 Q3
Q1 2023 4,966,197 -144,470,484 -97% 12 Apr 2023 10-Q 14 Apr 2023 2023 Q2
Q4 2022 1,257,927 -147,403,320 -99% 14 Jan 2023 10-Q 13 Jan 2023 2023 Q1
Q2 2022 1,257,927 -145,403,320 -99% 14 Jul 2022 10-Q 14 Jul 2022 2022 Q3
Q1 2022 149,436,681 +10,285,434 +7.4% 12 Apr 2022 10-Q 12 Apr 2022 2022 Q2
Q4 2021 148,661,247 +13,423,663 +9.9% 14 Jan 2022 10-Q 13 Jan 2022 2022 Q1
Q2 2021 146,661,247 +11,580,806 +8.6% 14 Jul 2021 10-Q 14 Jul 2021 2021 Q3
Q1 2021 139,151,247 +4,115,806 +3% 12 Apr 2021 10-Q 14 Apr 2021 2021 Q2
Q4 2020 135,237,584 +738,809 +0.55% 14 Jan 2021 10-Q 14 Jan 2021 2021 Q1
Q3 2020 135,080,441 04 Nov 2020 10-K 04 Nov 2020 2020 FY
Q2 2020 135,080,441 +621,666 +0.46% 14 Jul 2020 10-Q 14 Jul 2020 2020 Q3
Q1 2020 135,035,441 +576,666 +0.43% 12 Apr 2020 10-Q 13 Apr 2020 2020 Q2
Q4 2019 134,498,775 +80,000 +0.06% 29 Nov 2019 10-K 29 Nov 2019 2019 FY
Q2 2019 134,458,775 +13,387,890 +11% 14 Jul 2019 10-Q 15 Jul 2019 2019 Q3
Q1 2019 134,458,775 +13,973,103 +12% 12 Apr 2019 10-Q 15 Apr 2019 2019 Q2
Q4 2018 134,418,775 +14,853,935 +12% 14 Jan 2019 10-Q 14 Jan 2020 2020 Q1
Q2 2018 121,070,885 +2,748,264 +2.3% 13 Jul 2018 10-Q 16 Jul 2018 2018 Q3
Q1 2018 120,485,672 +5,329,717 +4.6% 04 Apr 2018 10-Q 05 Apr 2018 2018 Q2
Q4 2017 119,564,840 +5,444,162 +4.8% 14 Jan 2018 10-Q 16 Jan 2018 2018 Q1
Q2 2017 118,322,621 +12,535,956 +12% 14 Jul 2017 10-Q 17 Jul 2017 2017 Q3
Q1 2017 115,155,955 +9,369,290 +8.9% 18 Apr 2017 10-Q 14 Apr 2017 2017 Q2
Q4 2016 114,120,678 +11,967,345 +12% 17 Jan 2017 10-Q 17 Jan 2017 2017 Q1
Q2 2016 105,786,665 +4,873,332 +4.8% 12 Jul 2016 10-Q 13 Jul 2016 2016 Q3
Q1 2016 105,786,665 +5,063,332 +5% 08 Apr 2016 10-Q 18 Apr 2016 2016 Q2
Q4 2015 102,153,333 +1,520,000 +1.5% 31 Dec 2015 10-K 07 Jan 2016 2015 FY
Q2 2015 100,913,333 +19,152,927 +23% 15 Jul 2015 10-Q/A 17 Nov 2015 2015 Q3
Q1 2015 100,723,333 +79,843,130 +382% 17 Apr 2015 10-Q/A 17 Nov 2015 2015 Q2
Q4 2014 100,633,333 +79,953,130 +387% 12 Jan 2015 10-Q/A 17 Nov 2015 2015 Q1
Q2 2014 81,760,406 +81,080,204 +11920% 09 Jul 2014 10-Q 15 Jul 2014 2014 Q3
Q1 2014 20,880,203 +20,200,001 +2970% 15 Mar 2014 10-Q 01 Apr 2014 2014 Q2
Q4 2013 20,680,203 +20,000,001 +2940% 13 Jan 2014 10-Q 14 Jan 2014 2014 Q1
Q2 2013 680,202 0 0% 04 Jul 2013 10-Q 15 Jul 2013 2013 Q3
Q1 2013 680,202 0 0% 12 Apr 2013 10-Q 15 Apr 2013 2013 Q2
Q4 2012 680,202 0 0% 11 Jan 2013 10-Q 14 Jan 2013 2013 Q1
Q2 2012 680,202 05 Jul 2012 10-Q 06 Jul 2012 2012 Q3
Q1 2012 680,202 10 Apr 2012 10-Q 13 Apr 2012 2012 Q2
Q4 2011 680,202 14 Jan 2012 10-Q 13 Jan 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.